<> "The repository administrator has not yet configured an RDF license."^^ . <> . . . "Molecular epidemiology, transmission and clinical features of 2022‐mpox outbreak: A systematic review"^^ . "Background and Aims\nThe 2022-mpox outbreak has spread worldwide in a short time. Integrated knowledge of the epidemiology, clinical characteristics, and transmission of mpox are limited. This systematic review of peer-reviewed articles and gray literature was conducted to shed light on the epidemiology, clinical features, and transmission of 2022-mpox outbreak.\n\nMethods\nWe identified 45 peer-reviewed manuscripts for data analysis. The standards of the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) Statement and Cochrane Collaboration were followed for conducting the study.\n\nResults\nThe case number of mpox has increased about 100 times worldwide. About 99% of the cases in 2022 outbreak was from non-endemic regions. Men (70%–98% cases) were mostly infected with homosexual and bisexual behavior (30%–60%). The ages of the infected people ranged between 30 and 40 years. The presence of HIV and sexually transmitted infections among 30%–60% of cases were reported. Human-to-human transmission via direct contact and different body fluids were involved in the majority of the cases (90%–100%). Lesions in genitals, perianal, and anogenital areas were more prevalent. Unusually, pharyngitis (15%–40%) and proctitis (20%–40%) were more common during 2022 outbreak than pre-2022 outbreaks. Brincidofovir is approved for the treatment of smallpox by FDA (USA). Two vaccines, including JYNNEOSTM and ACAM2000®, are approved and used for pre- and post-prophylaxis in cases. About 100% of the cases in non-endemic regions were associated with isolates of IIb clade with a divergence of 0.0018–0.0035. Isolates from B.1 lineage were the most predominant followed by B.1.2 and B.1.10.\n\nConclusion\nThis study will add integrated knowledge of the epidemiology, clinical features, and transmission of mpox."^^ . "2023-10" . . . "6" . "10" . . "Health Science Reports"^^ . . . "23988835" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "Shuvra K."^^ . "Dey"^^ . "Shuvra K. Dey"^^ . . "Fuad M."^^ . "Alzahrani"^^ . "Fuad M. Alzahrani"^^ . . "Vivian"^^ . "Lipari"^^ . "Vivian Lipari"^^ . . "Anowar K."^^ . "Parvez"^^ . "Anowar K. Parvez"^^ . . "Miguel Ángel"^^ . "López Flores"^^ . "Miguel Ángel López Flores"^^ . . "Nazmul"^^ . "Sharif"^^ . "Nazmul Sharif"^^ . . "Isabel De la Torre"^^ . "Díez"^^ . "Isabel De la Torre Díez"^^ . . "Khalid J."^^ . "Alzahrani"^^ . "Khalid J. Alzahrani"^^ . . "Ibrahim F."^^ . "Halawani"^^ . "Ibrahim F. Halawani"^^ . . "Nadim"^^ . "Sharif"^^ . "Nadim Sharif"^^ . . . . . . "Molecular epidemiology, transmission and clinical features of 2022‐mpox outbreak: A systematic review (Texto)"^^ . . . "Health Science Reports - 2023 - Sharif - Molecular epidemiology transmission and clinical features of 2022‐mpox outbreak .pdf"^^ . . . "Molecular epidemiology, transmission and clinical features of 2022‐mpox outbreak: A systematic review (Otro)"^^ . . . . . . "indexcodes.txt"^^ . . "HTML Summary of #9232 \n\nMolecular epidemiology, transmission and clinical features of 2022‐mpox outbreak: A systematic review\n\n" . "text/html" . . . "Biomedicine"@en . "Biomedicina"@es . .